Marshall Financial Group LLC Purchases New Position in Amgen Inc.

The firm acquired 5,879 shares of the medical research company's stock, valued at approximately $1.9 million.

Mar. 23, 2026 at 10:49am

Marshall Financial Group LLC acquired a new stake in Amgen Inc. (NASDAQ:AMGN) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 5,879 shares of the medical research company's stock, valued at approximately $1,924,000.

Why it matters

This investment by Marshall Financial Group LLC in Amgen Inc. reflects the firm's belief in the long-term growth potential of the medical research company. Amgen is a major player in the biotechnology industry, focused on discovering, developing, and delivering human therapeutics to address serious illnesses.

The details

According to the 13F filing, Marshall Financial Group LLC acquired the 5,879 shares of Amgen stock during the 4th quarter. Amgen is a global biotechnology company headquartered in Thousand Oaks, California that specializes in biologic medicines derived from cellular and molecular biology.

  • Marshall Financial Group LLC acquired the Amgen shares during the 4th quarter of 2025.

The players

Marshall Financial Group LLC

An investment management firm that acquired a new stake in Amgen Inc.

Amgen Inc.

A global biotechnology company focused on discovering, developing, and delivering human therapeutics to address serious illnesses.

Got photos? Submit your photos here. ›

The takeaway

This investment by Marshall Financial Group LLC in Amgen Inc. demonstrates the firm's confidence in the long-term growth prospects of the biotechnology company as it continues to develop innovative treatments for patients.